Carregant...

Migration and invasion is inhibited by silencing ROR1 and ROR2 in chemoresistant ovarian cancer

Ovarian cancer survival remains poor despite recent advances in our understanding of genetic profiles. Unfortunately, the majority of ovarian cancer patients have recurrent disease after chemotherapy and lack other treatment options. Wnt signalling has been extensively implicated in cancer progressi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncogenesis
Autors principals: Henry, C E, Llamosas, E, Djordjevic, A, Hacker, N F, Ford, C E
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2016
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4945749/
https://ncbi.nlm.nih.gov/pubmed/27239958
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/oncsis.2016.32
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!